Ticker
NRIXCompany Name
NURIX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
9/30/2025 | $ -244.02M | -291.58% | $ 83.69M |
6/30/2025 | $ -206.47M | -233.61% | $ 88.38M |
3/31/2025 | $ -208.22M | -369.08% | $ 56.42M |
12/31/2024 | $ -193.3M | -354.36% | $ 54.55M |
9/30/2024 | $ -176.71M | -313.19% | $ 56.42M |
6/30/2024 | $ -164.82M | -264.55% | $ 62.3M |
3/31/2024 | $ -144.64M | -178.82% | $ 80.89M |
12/31/2023 | $ -143.95M | -186.98% | $ 76.99M |
9/30/2023 | $ -148.71M | -216.74% | $ 68.61M |
6/30/2023 | $ -157.44M | -258.37% | $ 60.94M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for NURIX THERAPEUTICS INC is calculated as follows: EBIT [ $ -63.78M ] / Revenues [ $ 17.82M ]
(=) EBIT % [ -357.9% ]
Minimum
Dec 31, 2022
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |